thiophenes has been researched along with Small Cell Lung Carcinoma in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Hong, Q; Li, X; Shen, J; Shen, W; Wang, H; Wei, T; Wen, G; Ye, W; Zhang, J; Zhang, Q; Zhang, W | 1 |
Baxi, SM; Estrella, H; Li, C; Liu, KK; Mehta, PP; Smeal, T; Walls, M; Yin, MJ; Zhu, J; Zientek, M; Zong, Q | 1 |
Bishop, PW; Blackhall, F; Critchlow, SE; Dive, C; Fusi, A; Hodgkinson, CL; Kelly, P; Morrow, CJ; Nonaka, D; PolaĆski, R; Priest, L; Smith, PD; Trapani, F; White, A | 1 |
Cummings, J; Dive, C; Kershaw, S; Morris, K; Tugwood, J | 1 |
Inoue, H; Kato, T; Matsuo, Y; Miyamoto, T; Nakamura, Y; Park, JH; Salgia, R; Zewde, M | 1 |
5 other study(ies) available for thiophenes and Small Cell Lung Carcinoma
Article | Year |
---|---|
SR9009 induces a REV-ERB dependent anti-small-cell lung cancer effect through inhibition of autophagy.
Topics: Animals; Antineoplastic Agents; Autophagy; Autophagy-Related Protein 5; Cell Line, Tumor; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Nuclear Receptor Subfamily 1, Group D, Member 1; Pyrrolidines; Receptors, Cytoplasmic and Nuclear; Repressor Proteins; Small Cell Lung Carcinoma; Thiophenes; Xenograft Model Antitumor Assays | 2020 |
Targeting small cell lung cancer harboring PIK3CA mutation with a selective oral PI3K inhibitor PF-4989216.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Class I Phosphatidylinositol 3-Kinases; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Humans; Immunoblotting; Lung Neoplasms; Mice; Mice, SCID; Mutation; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Small Cell Lung Carcinoma; Thiophenes; Triazoles; Xenograft Model Antitumor Assays | 2014 |
Activity of the monocarboxylate transporter 1 inhibitor AZD3965 in small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Humans; Inhibitory Concentration 50; Kaplan-Meier Estimate; Lactic Acid; Lung Neoplasms; Male; Mice; Mice, Inbred NOD; Mice, SCID; Middle Aged; Monocarboxylic Acid Transporters; Multivariate Analysis; Muscle Proteins; Pyrimidinones; Small Cell Lung Carcinoma; Symporters; Thiophenes; Xenograft Model Antitumor Assays | 2014 |
Optimisation of immunofluorescence methods to determine MCT1 and MCT4 expression in circulating tumour cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Clinical Trials, Phase I as Topic; Fluorescent Antibody Technique; Healthy Volunteers; Humans; Monocarboxylic Acid Transporters; Muscle Proteins; Neoplastic Cells, Circulating; Pyrimidinones; Small Cell Lung Carcinoma; Symporters; Thiophenes | 2015 |
TOPK (T-LAK cell-originated protein kinase) inhibitor exhibits growth suppressive effect on small cell lung cancer.
Topics: Cell Proliferation; Forkhead Box Protein M1; Humans; Lung Neoplasms; Mitogen-Activated Protein Kinase Kinases; Neoplastic Stem Cells; Quinolones; RNA Interference; RNA, Small Interfering; Small Cell Lung Carcinoma; Spheroids, Cellular; Thiophenes; Thy-1 Antigens; Tumor Cells, Cultured | 2017 |